Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota

Inflammation, injury, and infection up-regulate expression of the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1) in the intestinal epithelium. We studied the effects of cell-specific IDO1 expression in the epithelium at baseline and during intestinal inflammation in mice. We gen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2019-10, Vol.157 (4), p.1093-1108.e11
Hauptverfasser: Alvarado, David M., Chen, Baosheng, Iticovici, Micah, Thaker, Ameet I., Dai, Nattalie, VanDussen, Kelli L., Shaikh, Nurmohammad, Lim, Chai K., Guillemin, Gilles J., Tarr, Phillip I., Ciorba, Matthew A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1108.e11
container_issue 4
container_start_page 1093
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 157
creator Alvarado, David M.
Chen, Baosheng
Iticovici, Micah
Thaker, Ameet I.
Dai, Nattalie
VanDussen, Kelli L.
Shaikh, Nurmohammad
Lim, Chai K.
Guillemin, Gilles J.
Tarr, Phillip I.
Ciorba, Matthew A.
description Inflammation, injury, and infection up-regulate expression of the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1) in the intestinal epithelium. We studied the effects of cell-specific IDO1 expression in the epithelium at baseline and during intestinal inflammation in mice. We generated transgenic mice that overexpress fluorescence-tagged IDO1 in the intestinal epithelium under control of the villin promoter (IDO1-TG). We generated intestinal epithelial spheroids from mice with full-length Ido1 (controls), disruption of Ido1 (knockout mice), and IDO1-TG and analyzed them for stem cell and differentiation markers by real-time polymerase chain reaction, immunoblotting, and immunofluorescence. Some mice were gavaged with enteropathogenic Escherichia coli (E2348/69) to induce infectious ileitis, and ileum contents were quantified by polymerase chain reaction. Separate sets of mice were given dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid to induce colitis; intestinal tissues were analyzed by histology. We utilized published data sets GSE75214 and GDS2642 of RNA expression data from ilea of healthy individuals undergoing screening colonoscopies (controls) and patients with Crohn’s disease. Histologic analysis of small intestine tissues from IDO1-TG mice revealed increases in secretory cells. Enteroids derived from IDO1-TG intestine had increased markers of stem, goblet, Paneth, enteroendocrine, and tuft cells, compared with control enteroids, with a concomitant decrease in markers of absorptive cells. IDO1 interacted non-enzymatically with the aryl hydrocarbon receptor to inhibit activation of NOTCH1. Intestinal mucus layers from IDO1-TG mice were 2-fold thicker than mucus layers from control mice, with increased proportions of Akkermansia muciniphila and Mucispirillum schaedleri. Compared to controls, IDO1-TG mice demonstrated an 85% reduction in ileal bacteria (P = .03) when challenged with enteropathogenic E coli, and were protected from immune infiltration, crypt dropout, and ulcers following administration of dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid. In ilea of Crohn’s disease patients, increased expression of IDO1 correlated with increased levels of MUC2, LYZ1, and aryl hydrocarbon receptor, but reduced levels of SLC2A5. In mice, expression of IDO1 in the intestinal epithelial promotes secretory cell differentiation and mucus production; levels of IDO1 are positively correlated with secretory cell marke
doi_str_mv 10.1053/j.gastro.2019.07.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2261967632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508519410949</els_id><sourcerecordid>2261967632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-bdbc653b36c6bb534d808b0bc1d266f16cfb36fc6c918ac37b6e5f71279784123</originalsourceid><addsrcrecordid>eNp9kctuEzEUhkcIREPhDRDykkVn8CXjmdkgRWmhlRqQKKwtX86kjhw72B7EPBjvh9O0LFmdxX855-irqrcENwS37MOu2cqUY2goJkODuwYT9qxakJb2NcaEPq8WZfC6xX17Vr1KaYcxHlhPXlZnjDDaLmm_qP5cHWy-B2elQzfeBAdybz0gesHqSxt-z1vwMgEiaBPM5GSGhFZxduh6NjFoGVXw6BtoOOQQkfQGfQlZ36M7u_XSWb9FOZRiHeHYcmnHESL4bGW2JRhGdAdFK9kZrcG59FCxchki2kx6SvUqpaCLHQzaWB2DsiHL19WLUboEbx7nefXj09X39XV9-_XzzXp1W-sl7nOtjNK8ZYpxzZVq2dL0uFdYaWIo5yPheizaqLkeSC816xSHduwI7YauXxLKzqv3p95DDD8nSFnsbdLlTukhTElQysnAO86O1uXJWm5MKcIoDtHuZZwFweIITOzECZg4AhO4EwVYib173DCpPZh_oSdCxfDxZIDy5y8LUSRtwWswNoLOwgT7_w1_AYuSrDc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261967632</pqid></control><display><type>article</type><title>Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Alma/SFX Local Collection</source><creator>Alvarado, David M. ; Chen, Baosheng ; Iticovici, Micah ; Thaker, Ameet I. ; Dai, Nattalie ; VanDussen, Kelli L. ; Shaikh, Nurmohammad ; Lim, Chai K. ; Guillemin, Gilles J. ; Tarr, Phillip I. ; Ciorba, Matthew A.</creator><creatorcontrib>Alvarado, David M. ; Chen, Baosheng ; Iticovici, Micah ; Thaker, Ameet I. ; Dai, Nattalie ; VanDussen, Kelli L. ; Shaikh, Nurmohammad ; Lim, Chai K. ; Guillemin, Gilles J. ; Tarr, Phillip I. ; Ciorba, Matthew A.</creatorcontrib><description>Inflammation, injury, and infection up-regulate expression of the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1) in the intestinal epithelium. We studied the effects of cell-specific IDO1 expression in the epithelium at baseline and during intestinal inflammation in mice. We generated transgenic mice that overexpress fluorescence-tagged IDO1 in the intestinal epithelium under control of the villin promoter (IDO1-TG). We generated intestinal epithelial spheroids from mice with full-length Ido1 (controls), disruption of Ido1 (knockout mice), and IDO1-TG and analyzed them for stem cell and differentiation markers by real-time polymerase chain reaction, immunoblotting, and immunofluorescence. Some mice were gavaged with enteropathogenic Escherichia coli (E2348/69) to induce infectious ileitis, and ileum contents were quantified by polymerase chain reaction. Separate sets of mice were given dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid to induce colitis; intestinal tissues were analyzed by histology. We utilized published data sets GSE75214 and GDS2642 of RNA expression data from ilea of healthy individuals undergoing screening colonoscopies (controls) and patients with Crohn’s disease. Histologic analysis of small intestine tissues from IDO1-TG mice revealed increases in secretory cells. Enteroids derived from IDO1-TG intestine had increased markers of stem, goblet, Paneth, enteroendocrine, and tuft cells, compared with control enteroids, with a concomitant decrease in markers of absorptive cells. IDO1 interacted non-enzymatically with the aryl hydrocarbon receptor to inhibit activation of NOTCH1. Intestinal mucus layers from IDO1-TG mice were 2-fold thicker than mucus layers from control mice, with increased proportions of Akkermansia muciniphila and Mucispirillum schaedleri. Compared to controls, IDO1-TG mice demonstrated an 85% reduction in ileal bacteria (P = .03) when challenged with enteropathogenic E coli, and were protected from immune infiltration, crypt dropout, and ulcers following administration of dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid. In ilea of Crohn’s disease patients, increased expression of IDO1 correlated with increased levels of MUC2, LYZ1, and aryl hydrocarbon receptor, but reduced levels of SLC2A5. In mice, expression of IDO1 in the intestinal epithelial promotes secretory cell differentiation and mucus production; levels of IDO1 are positively correlated with secretory cell markers in ilea of healthy individuals and Crohn’s disease patients. We propose that IDO1 contributes to intestinal homeostasis. [Display omitted]</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2019.07.013</identifier><identifier>PMID: 31325428</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Bacteria - metabolism ; Basic Helix-Loop-Helix Transcription Factors - genetics ; Basic Helix-Loop-Helix Transcription Factors - metabolism ; Case-Control Studies ; Cell Differentiation ; Cell Line ; Cell Lineage ; Disease Models, Animal ; Epithelial Cells - enzymology ; Epithelial Cells - microbiology ; Epithelial Cells - pathology ; Gastrointestinal Microbiome ; Genotype ; Humans ; Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency ; Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics ; Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism ; Inflammatory Bowel Diseases - enzymology ; Inflammatory Bowel Diseases - genetics ; Inflammatory Bowel Diseases - microbiology ; Inflammatory Bowel Diseases - pathology ; Intestinal Mucosa - enzymology ; Intestinal Mucosa - microbiology ; Intestinal Mucosa - pathology ; Kynurenine ; Metabolism ; Mice, Knockout ; Microbiome ; Organoids ; Phenotype ; Receptors, Aryl Hydrocarbon - genetics ; Receptors, Aryl Hydrocarbon - metabolism ; Receptors, Notch - genetics ; Receptors, Notch - metabolism ; Secretory Pathway ; Signal Transduction ; Stem Cells - enzymology ; Stem Cells - microbiology ; Stem Cells - pathology ; Ulcerative Colitis</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2019-10, Vol.157 (4), p.1093-1108.e11</ispartof><rights>2019 AGA Institute</rights><rights>Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-bdbc653b36c6bb534d808b0bc1d266f16cfb36fc6c918ac37b6e5f71279784123</citedby><cites>FETCH-LOGICAL-c408t-bdbc653b36c6bb534d808b0bc1d266f16cfb36fc6c918ac37b6e5f71279784123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0016508519410949$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31325428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alvarado, David M.</creatorcontrib><creatorcontrib>Chen, Baosheng</creatorcontrib><creatorcontrib>Iticovici, Micah</creatorcontrib><creatorcontrib>Thaker, Ameet I.</creatorcontrib><creatorcontrib>Dai, Nattalie</creatorcontrib><creatorcontrib>VanDussen, Kelli L.</creatorcontrib><creatorcontrib>Shaikh, Nurmohammad</creatorcontrib><creatorcontrib>Lim, Chai K.</creatorcontrib><creatorcontrib>Guillemin, Gilles J.</creatorcontrib><creatorcontrib>Tarr, Phillip I.</creatorcontrib><creatorcontrib>Ciorba, Matthew A.</creatorcontrib><title>Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>Inflammation, injury, and infection up-regulate expression of the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1) in the intestinal epithelium. We studied the effects of cell-specific IDO1 expression in the epithelium at baseline and during intestinal inflammation in mice. We generated transgenic mice that overexpress fluorescence-tagged IDO1 in the intestinal epithelium under control of the villin promoter (IDO1-TG). We generated intestinal epithelial spheroids from mice with full-length Ido1 (controls), disruption of Ido1 (knockout mice), and IDO1-TG and analyzed them for stem cell and differentiation markers by real-time polymerase chain reaction, immunoblotting, and immunofluorescence. Some mice were gavaged with enteropathogenic Escherichia coli (E2348/69) to induce infectious ileitis, and ileum contents were quantified by polymerase chain reaction. Separate sets of mice were given dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid to induce colitis; intestinal tissues were analyzed by histology. We utilized published data sets GSE75214 and GDS2642 of RNA expression data from ilea of healthy individuals undergoing screening colonoscopies (controls) and patients with Crohn’s disease. Histologic analysis of small intestine tissues from IDO1-TG mice revealed increases in secretory cells. Enteroids derived from IDO1-TG intestine had increased markers of stem, goblet, Paneth, enteroendocrine, and tuft cells, compared with control enteroids, with a concomitant decrease in markers of absorptive cells. IDO1 interacted non-enzymatically with the aryl hydrocarbon receptor to inhibit activation of NOTCH1. Intestinal mucus layers from IDO1-TG mice were 2-fold thicker than mucus layers from control mice, with increased proportions of Akkermansia muciniphila and Mucispirillum schaedleri. Compared to controls, IDO1-TG mice demonstrated an 85% reduction in ileal bacteria (P = .03) when challenged with enteropathogenic E coli, and were protected from immune infiltration, crypt dropout, and ulcers following administration of dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid. In ilea of Crohn’s disease patients, increased expression of IDO1 correlated with increased levels of MUC2, LYZ1, and aryl hydrocarbon receptor, but reduced levels of SLC2A5. In mice, expression of IDO1 in the intestinal epithelial promotes secretory cell differentiation and mucus production; levels of IDO1 are positively correlated with secretory cell markers in ilea of healthy individuals and Crohn’s disease patients. We propose that IDO1 contributes to intestinal homeostasis. [Display omitted]</description><subject>Animals</subject><subject>Bacteria - metabolism</subject><subject>Basic Helix-Loop-Helix Transcription Factors - genetics</subject><subject>Basic Helix-Loop-Helix Transcription Factors - metabolism</subject><subject>Case-Control Studies</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cell Lineage</subject><subject>Disease Models, Animal</subject><subject>Epithelial Cells - enzymology</subject><subject>Epithelial Cells - microbiology</subject><subject>Epithelial Cells - pathology</subject><subject>Gastrointestinal Microbiome</subject><subject>Genotype</subject><subject>Humans</subject><subject>Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency</subject><subject>Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics</subject><subject>Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism</subject><subject>Inflammatory Bowel Diseases - enzymology</subject><subject>Inflammatory Bowel Diseases - genetics</subject><subject>Inflammatory Bowel Diseases - microbiology</subject><subject>Inflammatory Bowel Diseases - pathology</subject><subject>Intestinal Mucosa - enzymology</subject><subject>Intestinal Mucosa - microbiology</subject><subject>Intestinal Mucosa - pathology</subject><subject>Kynurenine</subject><subject>Metabolism</subject><subject>Mice, Knockout</subject><subject>Microbiome</subject><subject>Organoids</subject><subject>Phenotype</subject><subject>Receptors, Aryl Hydrocarbon - genetics</subject><subject>Receptors, Aryl Hydrocarbon - metabolism</subject><subject>Receptors, Notch - genetics</subject><subject>Receptors, Notch - metabolism</subject><subject>Secretory Pathway</subject><subject>Signal Transduction</subject><subject>Stem Cells - enzymology</subject><subject>Stem Cells - microbiology</subject><subject>Stem Cells - pathology</subject><subject>Ulcerative Colitis</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctuEzEUhkcIREPhDRDykkVn8CXjmdkgRWmhlRqQKKwtX86kjhw72B7EPBjvh9O0LFmdxX855-irqrcENwS37MOu2cqUY2goJkODuwYT9qxakJb2NcaEPq8WZfC6xX17Vr1KaYcxHlhPXlZnjDDaLmm_qP5cHWy-B2elQzfeBAdybz0gesHqSxt-z1vwMgEiaBPM5GSGhFZxduh6NjFoGVXw6BtoOOQQkfQGfQlZ36M7u_XSWb9FOZRiHeHYcmnHESL4bGW2JRhGdAdFK9kZrcG59FCxchki2kx6SvUqpaCLHQzaWB2DsiHL19WLUboEbx7nefXj09X39XV9-_XzzXp1W-sl7nOtjNK8ZYpxzZVq2dL0uFdYaWIo5yPheizaqLkeSC816xSHduwI7YauXxLKzqv3p95DDD8nSFnsbdLlTukhTElQysnAO86O1uXJWm5MKcIoDtHuZZwFweIITOzECZg4AhO4EwVYib173DCpPZh_oSdCxfDxZIDy5y8LUSRtwWswNoLOwgT7_w1_AYuSrDc</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Alvarado, David M.</creator><creator>Chen, Baosheng</creator><creator>Iticovici, Micah</creator><creator>Thaker, Ameet I.</creator><creator>Dai, Nattalie</creator><creator>VanDussen, Kelli L.</creator><creator>Shaikh, Nurmohammad</creator><creator>Lim, Chai K.</creator><creator>Guillemin, Gilles J.</creator><creator>Tarr, Phillip I.</creator><creator>Ciorba, Matthew A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota</title><author>Alvarado, David M. ; Chen, Baosheng ; Iticovici, Micah ; Thaker, Ameet I. ; Dai, Nattalie ; VanDussen, Kelli L. ; Shaikh, Nurmohammad ; Lim, Chai K. ; Guillemin, Gilles J. ; Tarr, Phillip I. ; Ciorba, Matthew A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-bdbc653b36c6bb534d808b0bc1d266f16cfb36fc6c918ac37b6e5f71279784123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Bacteria - metabolism</topic><topic>Basic Helix-Loop-Helix Transcription Factors - genetics</topic><topic>Basic Helix-Loop-Helix Transcription Factors - metabolism</topic><topic>Case-Control Studies</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cell Lineage</topic><topic>Disease Models, Animal</topic><topic>Epithelial Cells - enzymology</topic><topic>Epithelial Cells - microbiology</topic><topic>Epithelial Cells - pathology</topic><topic>Gastrointestinal Microbiome</topic><topic>Genotype</topic><topic>Humans</topic><topic>Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency</topic><topic>Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics</topic><topic>Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism</topic><topic>Inflammatory Bowel Diseases - enzymology</topic><topic>Inflammatory Bowel Diseases - genetics</topic><topic>Inflammatory Bowel Diseases - microbiology</topic><topic>Inflammatory Bowel Diseases - pathology</topic><topic>Intestinal Mucosa - enzymology</topic><topic>Intestinal Mucosa - microbiology</topic><topic>Intestinal Mucosa - pathology</topic><topic>Kynurenine</topic><topic>Metabolism</topic><topic>Mice, Knockout</topic><topic>Microbiome</topic><topic>Organoids</topic><topic>Phenotype</topic><topic>Receptors, Aryl Hydrocarbon - genetics</topic><topic>Receptors, Aryl Hydrocarbon - metabolism</topic><topic>Receptors, Notch - genetics</topic><topic>Receptors, Notch - metabolism</topic><topic>Secretory Pathway</topic><topic>Signal Transduction</topic><topic>Stem Cells - enzymology</topic><topic>Stem Cells - microbiology</topic><topic>Stem Cells - pathology</topic><topic>Ulcerative Colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alvarado, David M.</creatorcontrib><creatorcontrib>Chen, Baosheng</creatorcontrib><creatorcontrib>Iticovici, Micah</creatorcontrib><creatorcontrib>Thaker, Ameet I.</creatorcontrib><creatorcontrib>Dai, Nattalie</creatorcontrib><creatorcontrib>VanDussen, Kelli L.</creatorcontrib><creatorcontrib>Shaikh, Nurmohammad</creatorcontrib><creatorcontrib>Lim, Chai K.</creatorcontrib><creatorcontrib>Guillemin, Gilles J.</creatorcontrib><creatorcontrib>Tarr, Phillip I.</creatorcontrib><creatorcontrib>Ciorba, Matthew A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alvarado, David M.</au><au>Chen, Baosheng</au><au>Iticovici, Micah</au><au>Thaker, Ameet I.</au><au>Dai, Nattalie</au><au>VanDussen, Kelli L.</au><au>Shaikh, Nurmohammad</au><au>Lim, Chai K.</au><au>Guillemin, Gilles J.</au><au>Tarr, Phillip I.</au><au>Ciorba, Matthew A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2019-10</date><risdate>2019</risdate><volume>157</volume><issue>4</issue><spage>1093</spage><epage>1108.e11</epage><pages>1093-1108.e11</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>Inflammation, injury, and infection up-regulate expression of the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1) in the intestinal epithelium. We studied the effects of cell-specific IDO1 expression in the epithelium at baseline and during intestinal inflammation in mice. We generated transgenic mice that overexpress fluorescence-tagged IDO1 in the intestinal epithelium under control of the villin promoter (IDO1-TG). We generated intestinal epithelial spheroids from mice with full-length Ido1 (controls), disruption of Ido1 (knockout mice), and IDO1-TG and analyzed them for stem cell and differentiation markers by real-time polymerase chain reaction, immunoblotting, and immunofluorescence. Some mice were gavaged with enteropathogenic Escherichia coli (E2348/69) to induce infectious ileitis, and ileum contents were quantified by polymerase chain reaction. Separate sets of mice were given dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid to induce colitis; intestinal tissues were analyzed by histology. We utilized published data sets GSE75214 and GDS2642 of RNA expression data from ilea of healthy individuals undergoing screening colonoscopies (controls) and patients with Crohn’s disease. Histologic analysis of small intestine tissues from IDO1-TG mice revealed increases in secretory cells. Enteroids derived from IDO1-TG intestine had increased markers of stem, goblet, Paneth, enteroendocrine, and tuft cells, compared with control enteroids, with a concomitant decrease in markers of absorptive cells. IDO1 interacted non-enzymatically with the aryl hydrocarbon receptor to inhibit activation of NOTCH1. Intestinal mucus layers from IDO1-TG mice were 2-fold thicker than mucus layers from control mice, with increased proportions of Akkermansia muciniphila and Mucispirillum schaedleri. Compared to controls, IDO1-TG mice demonstrated an 85% reduction in ileal bacteria (P = .03) when challenged with enteropathogenic E coli, and were protected from immune infiltration, crypt dropout, and ulcers following administration of dextran sodium sulfate or 2,4,6-trinitrobenzenesulfonic acid. In ilea of Crohn’s disease patients, increased expression of IDO1 correlated with increased levels of MUC2, LYZ1, and aryl hydrocarbon receptor, but reduced levels of SLC2A5. In mice, expression of IDO1 in the intestinal epithelial promotes secretory cell differentiation and mucus production; levels of IDO1 are positively correlated with secretory cell markers in ilea of healthy individuals and Crohn’s disease patients. We propose that IDO1 contributes to intestinal homeostasis. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31325428</pmid><doi>10.1053/j.gastro.2019.07.013</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2019-10, Vol.157 (4), p.1093-1108.e11
issn 0016-5085
1528-0012
language eng
recordid cdi_proquest_miscellaneous_2261967632
source MEDLINE; Elsevier ScienceDirect Journals; Alma/SFX Local Collection
subjects Animals
Bacteria - metabolism
Basic Helix-Loop-Helix Transcription Factors - genetics
Basic Helix-Loop-Helix Transcription Factors - metabolism
Case-Control Studies
Cell Differentiation
Cell Line
Cell Lineage
Disease Models, Animal
Epithelial Cells - enzymology
Epithelial Cells - microbiology
Epithelial Cells - pathology
Gastrointestinal Microbiome
Genotype
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency
Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics
Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism
Inflammatory Bowel Diseases - enzymology
Inflammatory Bowel Diseases - genetics
Inflammatory Bowel Diseases - microbiology
Inflammatory Bowel Diseases - pathology
Intestinal Mucosa - enzymology
Intestinal Mucosa - microbiology
Intestinal Mucosa - pathology
Kynurenine
Metabolism
Mice, Knockout
Microbiome
Organoids
Phenotype
Receptors, Aryl Hydrocarbon - genetics
Receptors, Aryl Hydrocarbon - metabolism
Receptors, Notch - genetics
Receptors, Notch - metabolism
Secretory Pathway
Signal Transduction
Stem Cells - enzymology
Stem Cells - microbiology
Stem Cells - pathology
Ulcerative Colitis
title Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epithelial%20Indoleamine%202,3-Dioxygenase%201%20Modulates%20Aryl%20Hydrocarbon%20Receptor%20and%20Notch%20Signaling%20to%20Increase%20Differentiation%20of%20Secretory%20Cells%20and%20Alter%20Mucus-Associated%20Microbiota&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Alvarado,%20David%20M.&rft.date=2019-10&rft.volume=157&rft.issue=4&rft.spage=1093&rft.epage=1108.e11&rft.pages=1093-1108.e11&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2019.07.013&rft_dat=%3Cproquest_cross%3E2261967632%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261967632&rft_id=info:pmid/31325428&rft_els_id=S0016508519410949&rfr_iscdi=true